TNKS and lung cancer: Furthermore, the inhibition of the Wnt/β-catenin pathway by tankyrase inhibitors enhances the efficacy of EGFR inhibitor for the treatment of lung cancer [22], which suggests that tankyrase inhibitors could be used as adjuvant cancer treatments.